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The primary structure of nuclear factor-I (CTF/NF-I), a eukaryotic regulatory DNA-binding protein involved in both DNA replication and gene 
transcription, and the secondary structure predictable from it, are compared here with those of a number of prokaryotic acetylases. Hydropathy 
and Chou-Fasman analyses reveal that the polypeptide chain of CTF/NF-I is likely to fold to higher order structures imilar to those of the acetyl- 
ases, and significant conservation of functionally important regions of the acetylases i observed in CTF/NF-I. It is therefore suggested that CTF/ 
NF-I may function as a histone acetylase. 
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1. INTRODUCTION 
Eukaryotic chromatin involves two turns of DNA, 
approximately 140 bp [l], twined around a core 
nucleosome [2] consisting of pairs of histones 2A, 2B, 
3 and 4 while histone Hl binds to the linker region, a 
site between the entering and leaving DNA strands [3]. 
It has been suggested that Hl functions as a general 
repressor [4], and that this structure may therefore be 
analogous to prokaryotic nucleoids, in which repressors 
bind to loops of DNA bent by HU proteins [5]. 
Nucleosomes aggregate upon inactivation of the 
eukaryotic chromatin, forming continuous solenoid 
structures, and this process probably restricts the access 
of RNA polymerase [6]. 
A novel DNA binding unit has very recently been 
characterized in histones, recognition of the especially 
narrow DNA minor groove of A + T-rich regions taking 
place by means of an SPKK motif in the protein [7-91. 
This interaction may be of particular importance in the 
case of H2B, H3, H4 and Hl, and may serve to direct 
the formation of nucleosomes into A + T-rich regions 
[9,10]. On the other hand, the homeodomain-like 
globular domain of Hl is thought to be capable of 
sequence-specific interaction with DNA through an a- 
turn-a motif [6], and it may appear, therefore, that the 
interaction of the Hl C-terminus with A+ T-rich 
regions serves only to seal the nucleosome and gather 
the entering and leaving DNA strands. 
Eukaryotic RNA polymerases are generally thought 
to be capable of negotiating reconstituted eukaryotic 
nucleosomes in vitro [ll], although at a reduced rate 
when compared with a nucleosome-free template, in 
spite of the fact that the formation of nucleosomes 
evidently competes for the binding of transcriptional in- 
itiation complexes to the start site [ 12,131. Nucleosomes 
are present in vivo in the active areas of chromatin in 
most cases [14], although it has been suggested that 
H2A and H2B may become dissociated in some situa- 
tions [ 151 and one or two nucleosomes disappear from 
the transcriptional start site [ 161. It is generally thought 
that Hl becomes dissociated in the active areas, or is 
more loosely bound to the nucleosome although still 
present [ 171. As activation of chromatin is accompanied 
by modifications to the histones, including reversible 
acetylation of the SPKK motifs in the core histones 
[ 18-201, phosphorylation of a number of serines and 
threonines in Hl [22,23] and ubiquitination of H2A 
[24], and as introduction of these modifications has 
been demonstrated to impair interaction of the histones 
with DNA [25], the enzymes catalyzing their syntheses 
may be of crucial regulatory importance. 
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The primary structure of nuclear factor I (CTF/NF- 
I), a sequence-specific DNA binding protein that 
belongs to the family of CCAAT-binding proteins 
[26-291 and participates in the regulation of both DNA 
replication and transcription [30], has previously been 
demonstrated to display homology with the protein 
kinase (PK) family [31]. We concluded in a previous 
report that CTF/NF-I and the eukaryotic PKs may 
belong to a large gene family of regulatory proteins, the 
members of which are capable, to variable extents, of 
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recognizing a specific sequence on DNA and/or func- 
tioning as a PK. The primary structure of CTF/NF-I is 
compared here with sequences of prokaryotic origin in 
a genetic data bank and is observed to display 
homology with bacterial chloramphenicol 
acetyltransferases (CAT) [32-341. The observation thus 
suggests that CTF/NF-I may function as an acetylase, 
being evolutionarily related to the PKs. The acetylation 
of histones by CC~T-binding proteins may cause the 
loss of the nucleosome during gene activation obser- 
vable at the start of transcription. 
2. MATERIALS AND METHODS 
The computer programs described by Pustell and Kafatos [35-371 
were used for DNA and protein sequence analysis, and the GeneBank 
Genetic Sequence Data Bank to search for the various sequences. The 
Chou-Fasman analysis was performed as described previously [38]. 
3. RESULTS AND DISCUSSION 
Cloning of cDNAs for rat [26] and human CTFINF-I 
[27] and that of the corresponding porcine gene f2g] has 
recently been reported. Several forms of the protein, 
consisting of a maximum of 499 amino acid residues, 
have been synthesized as a result of differential splicing 
of primary transcripts from a single gene [27] or multi- 
ple genes [29], and the N-terminal part, containing a 
region subject to differential splicing in the middle of 
the final protein product and comprising about 200 
residues, ‘displays homology with catalytic domains in 
the PK family [31]. This region is thought to comprise 
the domain responsible for the sequence-specific 
recognition of DNA 139,401. 
The primary structure of CTF/NF-I was compared 
with sequences in a genetic data bank, and was observed 
by dot matrix analysis to display significant homology 
with CAT from a number of bacteria [32-341. The 
homologous area covered the entire length of the 
acetylases and 200 residues in the middle of CTF/NF-I, 
those containing the region subject to differential splic- 
ing (Fig. 1). The extreme C-terminal parts of the 
acetylases displayed homology with a C-terminal region 
in CTF/NF-I, thus leaving a 120-residue stretch of non- 
homology between the two homologous areas, similar 
to the comparison between CTFINF-I and the PKs 
[31]. The I20-residue area in CTF/NF-I is acidic, p1 
6.3, in contrast to the N-terminal part of the protein, 
which is basic, pl 11.8, and may therefore perform a 
specialized function. 
When the sequences of CAT and CTF/NF-I were 
aligned, major variations were observed in CTF/NF-I 
only in positions which varied even between the 
acetylases (Fig. 2). There are only two regions that are 
completely conserved in the various CAT proteins com- 
pared here, one with the sequence FTSFDLN from 154 
to 160 in the E. coli variant and the other with the se- 
quence HHAVCDG from 193 to 199. These sequences 
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Fig. 1. Schematic representation of homologous regions in CTF/NF- 
I, CAT and the catalytic subunit of PKA. The black areas display 
homology and the hatched ones differential splicing from primary 
transcripts in the case of CTF/NF-I. 
correspond to FSLGELQ and HTAIRYP in an 
analogous position in CTF/NF-I. It is also significant 
that the regions from 217 to 241 and 376 to 410 in 
CTF/NF-I, containing these conserved sequences, 
display respectively 32% and 27% identity when com- 
pared with the three CAT proteins. 
Hydropathy (Fig. 3) and Chou-Fasman analyses (Fig. 
2) revealed that CTF/NF-I may fold to higher order 
structures imilar to those of the various CAT proteins, 
the plots for CTFINF-I and E. cdi CAT being 
remarkably similar. The primary structures of the 4 
predicted cw-helices in CTF/NF-I turned out to be 
without exception much less well conserved between the 
CAT variants, and CAT and CTF/NF-I, than those of 
the predicted turns and P-strands, although the loca- 
tions of the helices approximately corresponded to 
those determined for CAT by crystallographic analysis 
of the type III variant of E. coli CAT [41]. 
Tertiary structures have been determined to date for 
a number of nucleotide-binding proteins including E. 
coli CAT, their characteristics being a core of several /3- 
strands and a shield consisting of c+helices towards the 
aqueous phase 1411. It is significant that the two most 
well-conserved sequences between CAT and CTF/NF- 
I, FTSFDLN and HHAVCDG, define two conserved 
loops demonstrated to be involved in recognition and 
hydrolysis of acetyl-CoA by CAT [41]. The correspon- 
ding loops in CTF/NF-I may therefore take part in pro- 
cessing of acetyl-CoA by that protein. His-195 of the 
type III variant of E. coli CAT, this corresponding to 
the latter His residue in the sequence HHAVCDG, has 
been suggested to function as a general base catalyst in 
the acetyl-transfer eaction and is well-conserved in the 
CTF/NF-I variants. 
The area undergoing differential splicing in 
CTF/NF-I may correspond to a loop in CAT which 
stabilizes the acetyl-CoA binding pouch, and may 
therefore confer a capability for processing acetyl-CoA 
on a portion of the CTF/NF-I molecules. The 
significance of the deletion of this region from some of 
the CTF/NF-I molecules remains to be elucidated, but 
it may be related to the dual role of CTF/NF-I, which 
is involved in the regulation of both DNA replication 
and the expression of different genes 1301. In the latter 
case a certain positio~ng of the CCAAT boxes is re- 
quired for adequate tr~scription efficiency, and a pro- 
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Fig. 2. Alignment of the primary structures of human CTF/NF-I and CAT proteins from various bacteria. Single letter codes for amino acids are 
used and gaps are introduced for maximal alignment. The shaded residues denote homology or a conservative r placement, he amino acids being 
grouped (P, A, G, S, T), (V, I, M, L), (D, N, E, Q), (K, R, H) and (F, Y, W). The predicted helices in CTF/NF-I are depicted by horizontal bars 
above the sequences and the helices determined by crystallographic methods in the type III variant of E. coli CAT below the sequences. Asterisks 
denote the residues responsible for recognition and processing of acetyl-CoA by CAT [41]. The region in brackets is the area subjected to alternative 
splicing in the case of CTF/NF-I. 
tein recognizing this motif may be of crucial importance 
for regulation purposes [42]. Differential splicing of 
certain regions of CTF/NF-I may most likely reflect 
variability in functionally unimportant areas of the pro- 
tein, however. 
100 
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Fig, 3. Hydropathy plots of the homologous regions in human 
CTF/NF-I (continuous line) and E. coli CAT (broken line). The most 
hydrophobic areas rank positive. 
It is therefore suggested here that at least a fraction of 
the CTF/NF-I molecules may function as histone 
acetylases in addition to recognizing a specific DNA se- 
quence. Consistent with this rationale, a histone 
acetylase isolated previously displays several 
characteristics imilar to CTF/NF-I [43]. This function 
of CTF/NF-I remains to be proved experimentally, but 
theoretically it is of the utmost interest, as it suggests 
that one mechanism for induction of the nucleosome 
loss during gene activation around the start of 
transcription [44,45] may be selective, directed protein 
lysine side-chain acetylation by sequence-specific DNA- 
binding proteins and consequent impairment of the 
DNA binding properties of the histones [18-201. This 
nucleosome loss may in this way enable the access of 
other transcription factors and RNA polymerase to the 
start site [46]. 
The present observation thus lends further support to 
the hypothesis which posits the existence of a large 
family of eukaryotic regulatory proteins of common 
evolutionary origin [3 11, a number of which are capable 
13 
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of sequence-specific binding to DNA through an (II- 
turn-cl! motif, or specific recognition of exogenous pro- 
teins, and which display some nucleotide processing ac- 
tivity. This protein family may contain PKs with DNA- 
binding capability such as CKIIU and cdd or ones lack- 
ing in it, such as PKA, PKC and PKG, and also some 
acetylases with DNA-binding properties such as 
CTF/NF-I. It may also include various G proteins, 
both those anchored to the plasma membrane and 
histone H 1, a nuclear G, (Mannermaa and Oikarinen, 
unpublished results). 
We have recently cloned the CTF/NF-I cDNA and 
are currently setting up a eukaryotic expression system 
for large-scale production of the corresponding protein 
in order to demonstrate the above enzymatic activity 
and to study the molecular structure of CTF/NF-I. 
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